The crosstalk between the liver, intestine and adipose tissue has shown that alterations in the release of intestinal hormones, such as incretins [5], or dysregulation of the gut microbiota [6] play an important role in the development and progression of NAFLD/NASH. This evidence concerns the gene GCG and metabolic dysfunction-associated steatohepatitis.